MA56065A - Polythérapie anticancéreuse mettant en oeuvre un composé de sulfonamide et un immunomodulateur - Google Patents

Polythérapie anticancéreuse mettant en oeuvre un composé de sulfonamide et un immunomodulateur

Info

Publication number
MA56065A
MA56065A MA056065A MA56065A MA56065A MA 56065 A MA56065 A MA 56065A MA 056065 A MA056065 A MA 056065A MA 56065 A MA56065 A MA 56065A MA 56065 A MA56065 A MA 56065A
Authority
MA
Morocco
Prior art keywords
polytherapy
immunomodulator
cancer
sulfonamide compound
sulfonamide
Prior art date
Application number
MA056065A
Other languages
English (en)
Inventor
Sayaka TSUKIOKA
Hiroyuki Ueno
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA56065A publication Critical patent/MA56065A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA056065A 2019-05-29 2020-05-28 Polythérapie anticancéreuse mettant en oeuvre un composé de sulfonamide et un immunomodulateur MA56065A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019100136 2019-05-29

Publications (1)

Publication Number Publication Date
MA56065A true MA56065A (fr) 2022-04-06

Family

ID=73553795

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056065A MA56065A (fr) 2019-05-29 2020-05-28 Polythérapie anticancéreuse mettant en oeuvre un composé de sulfonamide et un immunomodulateur

Country Status (8)

Country Link
US (1) US20220226291A1 (fr)
EP (1) EP3978017A4 (fr)
JP (1) JP7179174B2 (fr)
KR (1) KR102748684B1 (fr)
AU (1) AU2020283299B2 (fr)
MA (1) MA56065A (fr)
TW (1) TWI781405B (fr)
WO (1) WO2020241749A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4301735A4 (fr) * 2021-03-02 2025-05-21 Boundless Bio, Inc. Inhibiteurs de ribonucléotide réductase (rnr) et leurs utilisations
EP4402134A4 (fr) * 2021-09-17 2025-10-15 Boundless Bio Inc Inhibiteurs de ribonucléotide réductase (rnr) de sulfamide et leurs utilisations
KR20240101555A (ko) * 2021-09-17 2024-07-02 바운드리스 바이오, 인크. 사이클릭 설폰아미드 리보뉴클레오타이드 환원효소(rnr) 억제제 및 이의 용도
EP4587437A1 (fr) * 2022-09-13 2025-07-23 Boundless Bio, Inc. Inhibiteurs de ribonucléotide réductase (rnr) de sulfonamide cyclique et utilisations associées

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60334303D1 (de) 2002-07-03 2010-11-04 Tasuku Honjo Immunpotenzierende zusammensetzungen
AU2015203324B2 (en) * 2009-07-20 2016-07-28 Bristol-Myers Squibb Company Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
PL3099717T3 (pl) * 2014-01-31 2019-10-31 Novartis Ag Cząsteczki przeciwciała dla TIM-3 i ich zastosowanie
EA201691765A1 (ru) * 2014-03-14 2016-12-30 Новартис Аг Молекулы антител против lag-3 и их применения
EP3693019A1 (fr) * 2016-01-08 2020-08-12 Taiho Pharmaceutical Co., Ltd. Agent antitumoral contenant un immunomodulateur
ES2982299T3 (es) * 2016-05-31 2024-10-15 Taiho Pharmaceutical Co Ltd Compuestos de sulfonamida o sal de los mismos como inhibidores de ribonucleótido reductasa para el tratamiento del cáncer
JP7023690B2 (ja) 2017-12-06 2022-02-22 株式会社東芝 道路維持管理システム、道路維持管理方法及びコンピュータプログラム

Also Published As

Publication number Publication date
KR20220015430A (ko) 2022-02-08
TWI781405B (zh) 2022-10-21
TW202110442A (zh) 2021-03-16
AU2020283299B2 (en) 2024-08-01
AU2020283299A1 (en) 2022-02-03
EP3978017A4 (fr) 2023-06-28
WO2020241749A1 (fr) 2020-12-03
EP3978017A1 (fr) 2022-04-06
US20220226291A1 (en) 2022-07-21
KR102748684B1 (ko) 2025-01-02
JPWO2020241749A1 (fr) 2020-12-03
JP7179174B2 (ja) 2022-11-28

Similar Documents

Publication Publication Date Title
PL4018580T3 (pl) Wykorzystywanie skonfigurowanego zasobu informacji zwrotnych przeznaczonego dla informacji zwrotnych
DK4083038T3 (da) Pyridazinylthiazolcarboxamidforbindelse
IL280476A (en) Aerosol generating substrate
IL280499A (en) Aerosol generating substrate
EP3942152A4 (fr) Joints
MA54901A (fr) Inhibiteur de 15-pgdh
EP3910996A4 (fr) Rapport de csi sl
EP3919488A4 (fr) Immunomodulateur
IL280456A (en) Aerosol generating substrate
MA52090A (fr) Polythérapie
EP4286378A4 (fr) Composé pyrimidopyrane
EP3929362A4 (fr) Système de gestion de travail
IL280477A (en) Aerosol generation
EP3965669A4 (fr) Garrot à treuil
IL286750A (en) Semiconductor flipper
EP4045012A4 (fr) Systèmes multi-livrables auto-microémulsifiants
DK4090815T3 (da) Flange
EP4413158A4 (fr) Traitement atacseq à base de billes
DK3808747T3 (da) Imidazopyridinon-forbindelse
EP3698152A4 (fr) Plaque de guidage métallisée directe
EP4038302C0 (fr) Connexion à identification radiofréquence
EP3990393C0 (fr) Appareil d'extraction d'ammoniac
EP3939661A4 (fr) Timbre transdermique
IL285873A (en) Dissecting barrier
EP4076849C0 (fr) Appareil de travail